Checkpoint Therapeutics
On the heels of FDA nod for cancer drug, Sun Pharma buys Checkpoint Therapeutics for up to $416M
UNLOXCYT, Checkpoint Therapeutics, Squamous cell carcinoma of skin, United States Food and Drug Administration, Sun Pharma
Actionable Insights Powered by AI
UNLOXCYT, Checkpoint Therapeutics, Squamous cell carcinoma of skin, United States Food and Drug Administration, Sun Pharma